Stocks to buy

In the marketplace, tech advancements reign supreme. These three market disruptors are positioning themselves to transform various industries. Their revolutionary business models have a steadfast focus on strategic growth.

Read more to delve into the strategies and triumphs of these market disruptors. Unravel the secrets behind a potential to triple your investment. From expanding accommodation inventories to scaling telehealth services, these growth stocks serve as a roadmap towards a considerable price return based on disruption led by the companies.

Airbnb (ABNB)

Source: Diego Thomazini / Shutterstock

The fundamental core of Airbnb (NASDAQ:ABNB) is made of top-line growth and strategic priorities. For instance, Airbnb achieved revenue of $2.2 billion in Q4 2023, a 70% year-over-year growth. This rapid increase in revenue highlights the company’s capability to generate solid income. 

Fundamentally, Airbnb’s strategic priorities are vital to deriving its valuation expansion potential. There are three strategic priorities: uplifting the user experience, diversifying the portfolio and capturing emerging market trends.

Firstly, by making hosting mainstream, Airbnb aims to expand its host community and increase the supply of available listings. For instance, Airbnb’s host community hit over 5 million hosts in 2023. The active listings exceeded 7.7 million, an 18% year-over-year increase.

Secondly, Airbnb has introduced over 430 new features and upgrades to perfect the core service. These improvements focus on affordability, reliability and convenience for hosts and guests. For instance, there is a 36% decrease in post-cancellations in Q4 2023 compared to Q4 2022. Lastly, expanding beyond the core, the company leverages its firm grip on short-term rentals to venture into adjacent markets and offer additional services beyond accommodation booking.

SurgePays (SURG)

Source: Shutterstock

The telecommunications company SurgePays (NASDAQ:SURG) delivered a solid improvement in its gross profit margin during Q3 2023. Gross profit increased by 446% YOY. Similarly, the gross margin expanded to 30.7% from just 5.3% in Q3 2023 against Q3 2022. Fundamentally, the rapid improvement in gross profit margin suggests SurgePays’ emerging operational edge and cost optimization. 

Furthermore, this improvement toward bottom-line solidity suggests SurgePays’ capability to create value by maximizing the top line. A higher gross profit margin boosts the company’s bottom line with its competitive edge within the market, allowing SurgePays to reinvest profits into growth initiatives. Towards the bottom, SurgePays attained positive operating income during Q3 2023. As a result, the company had a net income of $7.1 million in Q3 against a net loss of $1.5 million in Q3 2022. This is a considerable improvement in the bottom line.

Moreover, the increase in revenues from mobile broadband and wireless services signifies the leadership of the core business model. This growth suggests the company’s fundamental capability to capture a larger market share within the target demographic by leveraging government-supported programs to expand its subscriber base. Overall, by aligning resources with high-growth opportunities and divesting from non-core operations, SurgePays may continue to improve its operational edge, bottom line and market valuations.

Teladoc Health (TDOC)

Source: Postmodern Studio /

Teladoc Health (NYSE:TDOC) can capitalize on considerable product and service demand. This suggests the value proposition of its portfolio to consumers, healthcare providers, and payers. In detail, there is enrollment growth at Teladoc Health in its chronic care programs.

Additionally active users surpassed 1.1 million indicating the increasing acceptance and utilization of virtual care solutions for managing chronic conditions. As a market trend, healthcare consumers are looking for more convenient and personalized options for managing their health. Teladoc Health’s chronic care programs now have an edgy market positioning due to improved patient outcomes and reduced healthcare costs.

Furthermore, the company leads in expanding chronic care program enrollment, with a 13% YOY increase. This reflects Teladoc Health’s edginess in engaging and retaining users through targeted interventions, personalized care plans and remote monitoring capabilities. Fundamentally, Teladoc Health’s capability to win over clients from competitors through a competitive edge suggests its prolonged differentiated value proposition and market lead. 

Moreover, Teladoc Health’s strong free cash flow generation reflects its financial standing. With Q3 free cash flow reaching $68 million, compared to $20 million in Q3 2022, the company has demonstrated its ability to convert revenue into cash. The free cash flow growth reflects Teladoc Health’s focus on driving the bottom line and liquidity from its core operations. Therefore, these developments may eventually support a higher valuation for Teladoc Health.

As of this writing, Yiannis Zourmpanos held a long position in TDOC. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.